| 000 | 01867 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517182421.0 | ||
| 264 | 0 | _c20180827 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1472-8206 | ||
| 024 | 7 |
_a10.1111/fcp.12328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBelaiche, Stéphanie | |
| 245 | 0 | 0 |
_aFactors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _cFeb 2018 |
||
| 300 |
_a88-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCalcineurin Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDécaudin, Bertrand | |
| 700 | 1 | _aDharancy, Sébastien | |
| 700 | 1 | _aGautier, Sophie | |
| 700 | 1 | _aNoel, Christian | |
| 700 | 1 | _aOdou, Pascal | |
| 700 | 1 | _aHazzan, Marc | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 32 _gno. 1 _gp. 88-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/fcp.12328 _zAvailable from publisher's website |
| 999 |
_c27721647 _d27721647 |
||